Home › Companies › INOVIO PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and INOVIO PHARMACEUTICALS INC.’s Form 8-K, filed May 22, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 20, 2025: 11 items on INOVIO PHARMACEUTICALS INC.’s Form 8-K, filed May 22, 2025: 11 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore INOVIO PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are INOVIO PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 22, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Simon X. Benito | 7,316,456 | -- | -- | 1,747,268 | 10,956,881 | 81% | Not verified | — |
| Elect Director: Roger D. Dansey, M.D. | 8,172,640 | -- | -- | 891,084 | 10,956,881 | 90% | Not verified | — |
| Elect Director: Ann C. Miller, M.D. | 8,360,784 | -- | -- | 702,940 | 10,956,881 | 92% | Not verified | — |
| Elect Director: Jacqueline E. Shea, Ph.D. | 8,283,381 | -- | -- | 780,343 | 10,956,881 | 91% | Not verified | — |
| Elect Director: Jay P. Shepard | 8,250,576 | -- | -- | 813,148 | 10,956,881 | 91% | Not verified | — |
| Elect Director: David B. Weiner, Ph.D. | 8,378,177 | -- | -- | 685,547 | 10,956,881 | 92% | Not verified | — |
| Elect Director: Wendy L. Yarno | 8,194,523 | -- | -- | 869,201 | 10,956,881 | 90% | Not verified | — |
| Elect Director: Lota S. Zoth | 8,421,250 | -- | -- | 642,474 | 10,956,881 | 93% | Not verified | — |
| 2. The ratification of the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 19,263,636 | 600,195 | 156,774 | -- | 0 | 97% | Not verified | — |
| 3. The approval, on a non-binding advisory basis, of the compensation of the NEOs described in the Proxy Statement | 7,853,003 | 1,058,436 | 152,285 | -- | 10,956,881 | 88% | Not verified | — |
| 4. The approval of the amendment and restatement of the Company's 2023 Omnibus Incentive Plan as described in the Proxy Statement | 7,764,469 | 1,165,985 | 133,270 | -- | 10,956,881 | 87% | Not verified | — |
Source: INOVIO PHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 22, 2025 — read the filing on EDGAR.
Each item below shows how the 145 asset managers that disclosed a INOVIO PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Ann C. Miller, M.D.
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ann C. Miller, M.D.”): 8,360,784 for, 702,940 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,171,298 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 5,726 | 0 | 0 | 0 | For |
| Jackson National | 4,833 | 0 | 0 | 0 | For |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 2,488 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: David B. Weiner, Ph.D.
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David B. Weiner, Ph.D.”): 8,378,177 for, 685,547 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,171,298 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 5,726 | 0 | 0 | 0 | For |
| Jackson National | 4,833 | 0 | 0 | 0 | For |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 2,488 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 4 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Jacqueline E. Shea, Ph.D.
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jacqueline E. Shea, Ph.D.”): 8,283,381 for, 780,343 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,171,298 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 5,726 | 0 | 0 | 0 | For |
| Jackson National | 4,833 | 0 | 0 | 0 | For |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 2,488 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Jay P. Shepard
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jay P. Shepard”): 8,250,576 for, 813,148 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,168,810 for, 2,488 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 5,726 | 0 | 0 | 0 | For |
| Jackson National | 4,833 | 0 | 0 | 0 | For |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,488 | Withhold |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Lota S. Zoth
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Lota S. Zoth”): 8,421,250 for, 642,474 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,160,739 for, 5,726 withheld, 4,833 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 5,726 | Withhold |
| Jackson National | 0 | 0 | 4,833 | 0 | Abstain |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 2,488 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Roger D. Dansey, M.D.
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Roger D. Dansey, M.D.”): 8,172,640 for, 891,084 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,168,661 for, 2,637 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 5,726 | 0 | 0 | 0 | For |
| Jackson National | 4,833 | 0 | 0 | 0 | For |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,488 | Withhold |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Simon X. Benito
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Simon X. Benito”): 7,316,456 for, 1,747,268 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,046,529 for, 119,936 withheld, 4,833 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 76,077 | Withhold |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 20,100 | Withhold |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 10,677 | Withhold |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 5,726 | Withhold |
| Jackson National | 0 | 0 | 4,833 | 0 | Abstain |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 2,698 | Withhold |
| Calvert | 0 | 0 | 0 | 2,488 | Withhold |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 1,121 | Withhold |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 900 | Withhold |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Wendy L. Yarno
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Wendy L. Yarno”): 8,194,523 for, 869,201 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,158,251 for, 8,214 withheld, 4,833 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 5,726 | Withhold |
| Jackson National | 0 | 0 | 4,833 | 0 | Abstain |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,488 | Withhold |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Combines 3 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE AN AMENDMENT AND RESTATEMENT OF OUR 2023 OMNIBUS INCENTIVE PLAN.
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“4. The approval of the amendment and restatement of the Company's 2023 Omnibus Incentive Plan as described in the Proxy Statement”): 7,764,469 for, 1,165,985 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 2,128,290 for, 43,142 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 0 | 43,142 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 5,726 | 0 | 0 | 0 | For |
| Jackson National | 4,833 | 0 | 0 | 0 | For |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 2,488 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.
Combines 7 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: To approve, on a non-binding advisory basis, the resolution regarding compensation of our named executive officers described in the accompanying proxy statement.
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“3. The approval, on a non-binding advisory basis, of the compensation of the NEOs described in the Proxy Statement”): 7,853,003 for, 1,058,436 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 0 | 5,726 | 0 | 0 | Against |
| Jackson National | 0 | 4,833 | 0 | 0 | Against |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 2,488 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Fund voting reports, all 30 managers: 2,160,739 for, 10,559 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 1,676,254 | 0 | 0 | 0 | For |
| Stonepine Capital Management, LLC | 701,123 | 0 | 0 | 0 | For |
| State Street | 474,552 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 366,958 | 0 | 0 | 0 | For |
| BlackRock | 324,970 | 0 | 0 | 0 | For |
| Northern Trust | 217,777 | 0 | 0 | 0 | For |
| Nuveen | 103,297 | 0 | 0 | 0 | For |
| Fidelity | 100,830 | 0 | 0 | 0 | For |
| Charles Schwab | 98,495 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 87,240 | 0 | 0 | 0 | For |
| CIBC Private Wealth Group LLC | 77,000 | 0 | 0 | 0 | For |
| GMT CAPITAL CORP | 68,749 | 0 | 0 | 0 | For |
| Two Sigma | 63,948 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 61,671 | 0 | 0 | 0 | For |
| UBS | 43,445 | 201 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| Vanguard | 37,829 | 0 | 0 | 0 | For |
| Citadel | 28,014 | 0 | 0 | 0 | For |
| Freedom Investment Management, Inc. | 19,230 | 0 | 0 | 0 | For |
| Dimensional | 0 | 18,743 | 0 | 0 | Against |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 13,400 | 0 | 0 | Against |
| Invesco | 10,761 | 0 | 0 | 0 | For |
| WASHINGTON STATE INVESTMENT BOARD | 10,577 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 10,551 | 0 | 0 | 0 | For |
| T. Rowe Price | 10,177 | 0 | 0 | 0 | For |
Institutional-manager reports, all 127 managers: 4,739,143 for, 43,434 against. Showing the 25 largest; see all in the interactive database.
97% Majority: yes · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
INOVIO PHARMACEUTICALS INC.’s own tally for this item (“2. The ratification of the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 19,263,636 for, 600,195 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 30 asset managers below reported 2,171,149 for, 149 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 783,493 | 0 | 0 | 0 | For |
| BlackRock | 588,634 | 0 | 0 | 0 | For |
| Fidelity | 321,735 | 0 | 0 | 0 | For |
| Charles Schwab | 98,493 | 0 | 0 | 0 | For |
| Northern Trust | 76,077 | 0 | 0 | 0 | For |
| TIAA | 46,491 | 0 | 0 | 0 | For |
| American Century | 43,142 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,306 | 0 | 0 | 0 | For |
| Equitable | 24,231 | 0 | 0 | 0 | For |
| Global X | 20,757 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,316 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,708 | 0 | 0 | 0 | For |
| Pacific Life | 15,226 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,215 | 0 | 0 | 0 | For |
| State Street | 10,677 | 0 | 0 | 0 | For |
| ProShares | 7,824 | 0 | 0 | 0 | For |
| Dimensional | 5,726 | 0 | 0 | 0 | For |
| Jackson National | 4,833 | 0 | 0 | 0 | For |
| Nationwide | 3,448 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,030 | 0 | 0 | 0 | For |
| Voya | 2,698 | 0 | 0 | 0 | For |
| Calvert | 2,488 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,121 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 36,674,436 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.14% |
| 2 | BlackRock | 1.61% |
| 3 | Fidelity | 0.88% |
| 4 | Charles Schwab | 0.27% |
| 5 | Northern Trust | 0.21% |
| 6 | TIAA | 0.13% |
| 7 | American Century | 0.12% |
| 8 | QUANTITATIVE MASTER SERIES LLC | 0.10% |
| 9 | Equitable | 0.07% |
| 10 | Global X | 0.06% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Deep Track Capital, LP | 4.57% |
| 2 | Stonepine Capital Management, LLC | 1.91% |
| 3 | State Street | 1.29% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.00% |
| 5 | BlackRock | 0.89% |
| 6 | Northern Trust | 0.59% |
| 7 | Nuveen | 0.28% |
| 8 | Fidelity | 0.27% |
| 9 | Charles Schwab | 0.27% |
| 10 | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0.24% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 18.18% | 13G |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 16.88% | 13G |
| Adage Capital Management, L.P. | 11.54% | 13G |
| Alyeska Investment Group, L.P. | 10.91% | 13G |
| Highbridge Capital Management, LLC | 9.91% | 13G |
| BlackRock | 6.32% | 13F |
| Vanguard Group | 5.53% | 13F |
| Stonepine Capital Management, LLC | 3.91% | 13G |
| Geode Capital | 2.31% | 13F |
| State Street | 1.40% | 13F |
Percentages above are of 36,674,436 shares outstanding, as reported by INOVIO PHARMACEUTICALS INC. on its Form 10-Q dated May 9, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from INOVIO PHARMACEUTICALS INC.’s 10-Q dated May 9, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At INOVIO PHARMACEUTICALS INC.'s shareholder meeting held May 20, 2025, in the 2024-2025 proxy season, 145 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 981 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the resolution regarding compensation of our named… — FOR was 88% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: INOVIO PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 22, 2025.
INOVIO PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.